Literature DB >> 17172943

National collaborative study groups: structure, benefits gained and potential for rare genetic diseases.

Theodore B Moore1, Edward R B McCabe.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 17172943     DOI: 10.1097/gim.0b013e31802bd96a

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  3 in total

Review 1.  Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage.

Authors:  Ajay Major; Monica Palese; Ebru Ermis; Anthony James; Milena Villarroel; Federico Antillon Klussmann; Laila Hessissen; Jennifer Geel; Muhammad Saghir Khan; Rashmi Dalvi; Michael Sullivan; Pamela Kearns; A Lindsay Frazier; Kathy Pritchard-Jones; Akira Nakagawara; Carlos Rodriguez-Galindo; Samuel L Volchenboum
Journal:  JCO Glob Oncol       Date:  2022-02

Review 2.  Pharmacogenomic testing in paediatrics: Clinical implementation strategies.

Authors:  Charlotte I S Barker; Gabriella Groeneweg; Anke H Maitland-van der Zee; Michael J Rieder; Daniel B Hawcutt; Tim J Hubbard; Jesse J Swen; Bruce C Carleton
Journal:  Br J Clin Pharmacol       Date:  2022-02-07       Impact factor: 3.716

Review 3.  Achieving the "triple aim" for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence framework.

Authors:  Beth K Potter; Pranesh Chakraborty; Jonathan B Kronick; Kumanan Wilson; Doug Coyle; Annette Feigenbaum; Michael T Geraghty; Maria D Karaceper; Julian Little; Aizeddin Mhanni; John J Mitchell; Komudi Siriwardena; Brenda J Wilson; Ania Syrowatka
Journal:  Genet Med       Date:  2012-12-06       Impact factor: 8.822

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.